The Obesity & Weight Management Alliance is delighted to unveil the speaker line-up and agenda for its 2026 UK and Ireland conference series – an essential event for healthcare professionals committed to advancing obesity care.

The Obesity & Weight Management Alliance has announced a nationwide call for poster submissions ahead of its 2026 conference series, which promises to be the most extensive yet.

Registrations are now open for the 2026 Obesity & Weight Management Alliance Conferences – returning for a third consecutive year with an expanded format to meet growing demand from UK healthcare professionals.

The Trustees of the Novo Nordisk UK Research Foundation (NNUKRF) and the Diabetes Care Trust are encouraging diabetes healthcare professionals to apply for a series of funding opportunities now open for applications.

Trend Diabetes has released a brand-new educational video “How to examine for lipohypertrophy,” delivered by Debbie Hicks, Chair of Trend Diabetes.

The Diabetes Africa UK Forum returns for its third year in 2025, continuing its mission to advance equity in diabetes care for Black populations.

People from Afro-Caribbean and South Asian backgrounds are less likely to be prescribed “life-changing” diabetes technology compared to White individuals, a new study has reported.

The first ever immunotherapy for type 1 diabetes has now been licensed for use in the UK.

A leading blood glucose testing company has launched a range of products with Well Pharmacy.

New research has identified a growing confidence among UK nurses and midwives in supporting people with diabetes using continuous glucose monitoring (CGM) technologies, but not so much hybrid closed-loop (HCL) systems.

Hypo Awareness Week is back from the 6 to 12 October 2025, bringing together registered healthcare professionals from across the UK and Ireland to highlight the dangers of hypoglycaemia.

The parents of a two-year-old girl who died from undiagnosed type 1 diabetes are campaigning for a new law to ensure babies and children are routinely tested for the condition as part of medical assessments.